BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2892010)

  • 1. "Intermediate" doses of tamoxifen in progressive advanced breast-cancer.
    Watkins SM
    Lancet; 1987 Dec; 2(8573):1457. PubMed ID: 2892010
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comparison of two doses of tamoxifen in patients with advanced breast cancer: 20 mg/day versus 40 mg/day].
    Takatsuka Y; Yayoi E; Inaji H; Aikawa T
    Gan To Kagaku Ryoho; 1989 May; 16(5):2093-7. PubMed ID: 2658841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of anti-oestrogen Zitazonium (tamoxifen) as adjuvant to cytostatic treatment in metastatic breast cancer.
    Palka I; Jávor J
    Ther Hung; 1986; 34(4):217-23. PubMed ID: 3449976
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tamoxifen therapy for advanced breast cancer by oral administration (author's transl)].
    Yoshida M; Murai H; Miura S
    Horumon To Rinsho; 1980 Aug; 28(8):929-37. PubMed ID: 7460340
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of advanced breast cancer effectively treated with tamoxifen].
    Nakagawa K; Shibata C; Momono S; Sasaki Y; Furusawa A; Sato T
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1391-4. PubMed ID: 1503489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of high dose tamoxifen in postmenopausal breast cancer patients progressing on standard doses: a pilot study.
    Watkins SM
    Br J Cancer; 1988 Mar; 57(3):320-1. PubMed ID: 3355772
    [No Abstract]   [Full Text] [Related]  

  • 7. Tamoxifen withdrawal response. Report of a case.
    Belani CP; Pearl P; Whitley NO; Aisner J
    Arch Intern Med; 1989 Feb; 149(2):449-50. PubMed ID: 2537066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of recurrent breast cancer responding to long-term administration of tamoxifen].
    Yayoi E; Kobayashi T; Inaji H; Maeura Y; Mori T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1683-6. PubMed ID: 6433801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of breast cancer with multiple bone metastases effectively treated with UFT and tamoxifen].
    Endo F; Ishii T; Kito T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):851-4. PubMed ID: 2496670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of tamoxifen for advanced and recurrent breast cancer (author's transl)].
    Horumon To Rinsho; 1980 Apr; 28(4):425-36. PubMed ID: 7006865
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer.
    Alonso-Muñoz MC; Ojeda-González MB; Beltran-Fabregat M; Dorca-Ribugent J; López-López L; Borrás-Balada J; Cardenal-Alemany F; Gómez-Batiste X; Fabregat-Mayol J; Viladiu-Quemada P
    Oncology; 1988; 45(5):350-3. PubMed ID: 3045726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of tamoxifen dose escalation in advanced breast cancer.
    Goldhirsch A; Joss RA; Leuenberger U; Cavalli F; Ryssel HJ; Brunner KW
    Am J Clin Oncol; 1982 Oct; 5(5):501-3. PubMed ID: 7180828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer and duration of tamoxifen.
    Prescrire Int; 2015 Sep; 24(163):220. PubMed ID: 26417636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant tamoxifen and chemotherapy prolongs life and increases disease-free survival of women with breast cancer.
    Oncology (Williston Park); 1992 Jan; 6(1):86. PubMed ID: 1531606
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antiestrogens in the treatment of advanced breast cancer].
    Płuzańska A; Smiałowska A; Stempczyńska J; Wator A
    Pol Tyg Lek; 1989 Feb 13-20; 44(7-8):191-4. PubMed ID: 2813178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The results of a comparative clinical study of the antiestrogenic preparations toremifene and tamoxifen in locally advanced and disseminated breast cancer].
    Konstantinova MM; Gershanovich MA
    Vopr Onkol; 1990; 36(10):1182-6. PubMed ID: 2147527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combined tamoxifen and medroxyprogesterone treatment on coagulation-fibrinolytic systems in patients with advanced breast cancer.
    Fukutomi T; Adachi I; Watanabe T; Nanasawa T; Yamamoto H
    Acta Oncol; 1993; 32(5):573-4. PubMed ID: 8217244
    [No Abstract]   [Full Text] [Related]  

  • 18. [Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer].
    Novoa Vargas A; Font López KC; Amador DD
    Ginecol Obstet Mex; 2011 Sep; 79(9):553-7. PubMed ID: 21966856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment of metastasizing breast carcinoma using antiestrogens].
    Pienkowski T; Palucka-Bartoszewicz A; Pienkowska F; Zborzil J; Schneider J
    Wien Med Wochenschr; 1991; 141(13):294, 297-300. PubMed ID: 1926878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Breast cancer with multiple metastases: treatment with tamoxifen].
    Negriguladi C
    Nouv Presse Med; 1978 Mar; 7(12):1034. PubMed ID: 662618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.